Densitas Enters Platform Partnership with Blackford

Densitas announces the signing of a new Alliance Partner Agreement with Blackford. This agreement gives Blackford the right to promote, market, sell, distribute, and license densitasdensity™ directly via integration with the Blackford PlatformTM. Work will now commence to integrate densitasdensity™ with the Blackford Platform.

Read More
Mohamed Abdolell
Densitas Receives 510(k) Clearance for Breast Density Software

Breast imaging analytics innovator Densitas Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its machine learning breast density assessment software.

The software empowers radiologists with standardized, personalized and automated density reports to optimize women’s breast health and follow-up care decisions.

Read More
Mohamed Abdolell
Research Highlights Performance of Densitas Software, Importance of Breast Density Measurements in Breast Cancer Risk Models

Densitas Inc., developer of advanced breast imaging analytics technologies, announced today that research is being presented at this year’s British Society of Breast Radiology (BSBR) scientific meeting that highlights the contribution the company’s automated breast density software, DM-Density, can make to clinical workflows. 

Read More
Mohamed Abdolell
Densitas Announces Presentation Of Abstracts At ECR

Research Highlights Densitas Breast Density Software Processes Standard Digital Mammograms. Densitas Inc, developer of advanced breast imaging analytics technologies, announced today that research will be presented at the European Congress of Radiology (ECR) that highlights the company’s automated breast density software, DM-Density.

Read More
Mohamed Abdolell